
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
In 2018, 9 states reported an adult obesity prevalence of ≥35%. Find out more trends from the CDCs annual Adult Obesity Prevalence Maps.
The US Centers for Disease Control and Prevention recently released the 2018 Adult Obesity Prevalence Maps, which use data from the Behavioral Risk Factor Surveillance System to show the prevalence of self-reported obesity broken down by race, ethnicity, and location in persons aged â¥18 years. The maps show key differences between populations across all US states and territories. Answer the 6 questions below to find out more about key findings.Â






